Goldman Sachs
SSKN

Goldman Sachs’s Strata Skin Sciences SSKN Stock Holding History

Goldman Sachs’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,587
Closed -$9.78K – 5907
2024
Q1 		$9.78K Sell
2,587
-4,016
-61% -$21K ﹤0.01% 5433
2023
Q4 		$36.3K Hold
6,603
– – ﹤0.01% 5411
2023
Q3 		$39.3K Buy
6,603
+2
+0% +$15 ﹤0.01% 5302
2023
Q2 		$62.7K Buy
6,601
+1
+0% +$10 ﹤0.01% 5438
2023
Q1 		$69.9K Sell
6,600
-3
-0% -$30 ﹤0.01% 5505
2022
Q4 		$52.2K Sell
6,603
-1,816
-22% -$15.6K ﹤0.01% 5589
2022
Q3 		$73K Sell
8,419
-11,440
-58% -$116K ﹤0.01% 5752
2022
Q2 		$191K Hold
19,859
– – ﹤0.01% 5661
2022
Q1 		$292K Hold
19,859
– – ﹤0.01% 5677
2021
Q4 		$291K Hold
19,859
– – ﹤0.01% 5685
2021
Q3 		$365K Hold
19,859
– – ﹤0.01% 5384
2021
Q2 		$310K Sell
19,859
-30
-0.2% -$467 ﹤0.01% 5500
2021
Q1 		$332K Buy
19,889
+30
+0.2% +$544 ﹤0.01% 5371
2020
Q4 		$298K Sell
19,859
-874
-4% -$12.6K ﹤0.01% 4889
2020
Q3 		$280K Buy
20,733
+868
+4% +$12K ﹤0.01% 4771
2020
Q2 		$228K Hold
19,865
– – ﹤0.01% 4741
2020
Q1 		$189K Buy
19,865
+1
+0% +$17 ﹤0.01% 4729
2019
Q4 		$413K Sell
19,864
-1,585
-7% -$36K ﹤0.01% 4606
2019
Q3 		$461K Buy
+21,449
New +$502K ﹤0.01% 4490
2018
Q4 		– Sell
-5,965
Closed -$211K – 5635
2018
Q3 		$211K Buy
+5,965
New +$147K ﹤0.01% 4897
2017
Q3 		– Sell
-1,205
Closed -$29K – 6848
2017
Q2 		$29K Buy
1,205
+825
+217% +$23K ﹤0.01% 6480
2017
Q1 		$12K Sell
380
-56
-13% -$1.59K ﹤0.01% 6596
2016
Q4 		$10K Buy
436
+85
+24% +$2.17K ﹤0.01% 6764
2016
Q3 		$9K Sell
351
-42
-11% -$1.34K ﹤0.01% 6885
2016
Q2 		$12K Sell
393
-54
-12% -$2.17K ﹤0.01% 6832
2016
Q1 		$21K Buy
447
+88
+25% +$4.55K ﹤0.01% 6737
2015
Q4 		$20K Hold
359
– – ﹤0.01% 6847
2015
Q3 		$20K Buy
+359
New +$20.8K ﹤0.01% 7034
2015
Q2 		– Sell
-386
Closed -$50K – 7423
2015
Q1 		$50K Buy
+386
New +$38.1K ﹤0.01% 6688
2014
Q4 		– Sell
-851
Closed -$73K – 7306
2014
Q3 		$73K Buy
851
+695
+446% +$81.5K ﹤0.01% 6709
2014
Q2 		$25K Buy
156
+40
+34% +$9.07K ﹤0.01% 6852
2014
Q1 		$36K Sell
116
-3
-3% -$1.05K ﹤0.01% 6622
2013
Q4 		$38K Sell
119
-3
-2% -$1.07K ﹤0.01% 6469
2013
Q3 		$45K Buy
122
+27
+28% +$10.8K ﹤0.01% 6329
2013
Q2 		$44K Buy
+95
New +$50.9K ﹤0.01% 6077

Other funds holding SSKN

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs's SSKN Position: Q2 2024 in Review

Goldman Sachs sold out of Strata Skin Sciences (SSKN) in Q2 2024, closing a stake of 2,587 shares — an estimated $9.78K sold.

Goldman Sachs first reported a position in SSKN in Q2 2013 and held it in 35 quarters. The position peaked at $461K in Q3 2019. 17 funds tracked by Wall St. Rank hold SSKN as of Q2 2024.

  • Goldman Sachs reported no remaining Strata Skin Sciences position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 2,587 Strata Skin Sciences shares in Q2 2024, an estimated $9.78K.
  • Goldman Sachs first reported a position in Strata Skin Sciences in Q2 2013 and held it in 35 quarters.
  • Goldman Sachs's Strata Skin Sciences position peaked at $461K in Q3 2019.
  • 17 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.